Who owns mots stock?
There are some very high-powered funds/investment advisors holding major stakes in MOTS. Those include 4.2 M shares owned by Perceptive Advisors, 3.8 M shares owned by Oracle Investment Management, and 2.9 M shares owned by Armistice Capital.
How does mots compare to other US stocks?
MOTS has a higher market value than only 2.82% of US stocks; more precisely, its current market capitalization is $23,028,338. MOTS's price/sales ratio is 70.21; that's higher than the P/S ratio of 96.45% of US stocks.
What stocks are similar to Motus GI Holdings Inc (mots)?
If you're looking for stocks that are quantitatively similar to Motus GI Holdings Inc, a group of peers worth examining would be DMRC, UCL, BFLY, STXS, and WRAP. MOTS's SEC filings can be seen here. And to visit Motus GI Holdings Inc's official web site, go to www.motusgi.com.
Why should I invest in mots shares?
MOTS shares are being given away at a bargain in the current market. Anyone who knows of a friend or relative who has had a "failed" colonoscopy because, despite extensive & burdensome preparations required for the colonoscopy, can have a true appreciation for the invaluable role Pure-Vu can play for a majority of colonoscopy procedures.
Is MOTS stock a good buy?
According to the issued ratings of 3 analysts in the last year, the consensus rating for Motus GI stock is Buy based on the current 3 buy ratings for MOTS. The average twelve-month price prediction for Motus GI is $1.47 with a high price target of $1.50 and a low price target of $1.40.
Is Motus stock a buy?
Motus GI has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 4 buy ratings, no hold ratings, and no sell ratings.
Should I buy or sell Motus GI stock right now?
2 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Motus GI in the last year. There are currently 2 buy rat...
What is Motus GI's stock price forecast for 2022?
2 analysts have issued 1 year target prices for Motus GI's stock. Their forecasts range from $1.40 to $1.50. On average, they expect Motus GI's sha...
How has Motus GI's stock price performed in 2022?
Motus GI's stock was trading at $0.4670 on January 1st, 2022. Since then, MOTS stock has decreased by 43.5% and is now trading at $0.2637. View th...
When is Motus GI's next earnings date?
Motus GI is scheduled to release its next quarterly earnings announcement on Thursday, August 11th 2022. View our earnings forecast for Motus GI .
How were Motus GI's earnings last quarter?
Motus GI Holdings, Inc. (NASDAQ:MOTS) issued its earnings results on Tuesday, March, 29th. The company reported ($0.10) EPS for the quarter, hittin...
Who are Motus GI's key executives?
Motus GI's management team includes the following people: Mr. Timothy P. Moran , CEO & Director (Age 50, Pay $787.33k) ( LinkedIn Profile ) Mr....
Who are some of Motus GI's key competitors?
Some companies that are related to Motus GI include Pro-Dex (PDEX) , Titan Medical (TMDI) , Biostage (BSTG) , Daxor (DXR) , SANUWAVE Health (S...
What other stocks do shareholders of Motus GI own?
Based on aggregate information from My MarketBeat watchlists, some companies that other Motus GI investors own include Matinas BioPharma (MTNB) ,...
When did Motus GI IPO?
(MOTS) raised $21 million in an IPO on Wednesday, February 14th 2018. The company issued 3,500,000 shares at a price of $5.00-$7.00 per share. Pipe...
About Motus GI
Motus GI (NASDAQ:MOTS) Frequently Asked Questions
Motus GI Holdings, Inc. is a medical technology company, which is dedicated to improving endoscopy outcomes and experiences. It engages in the development and commercialization of the Pure-Vu System to improve the colonoscopy experience and assist in the early detection and prevention of colorectal cancer and other diseases of the rectum and colon.
Component Grades
3 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Motus GI in the last year. There are currently 3 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" Motus GI stock. View analyst ratings for Motus GI or view top-rated stocks.
MOTS POWR Grades
We have 9 different ratings for every stock to help you appreciate its future potential. You can unlock it all now.
MOTS Stock Summary
Growth is the dimension where MOTS ranks best; there it ranks ahead of 84.46% of US stocks.
MOTS Valuation Summary
MOTS has a higher market value than only 2.82% of US stocks; more precisely, its current market capitalization is $23,028,338.
MOTS's Quality Factors
In comparison to the median Healthcare stock, MOTS's EV/EBIT ratio is 103.75% lower, now standing at -1.1.
Signals & Forecast
The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.
Support, Risk & Stop-loss
Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. The Motus GI Holdings Inc.
Is Motus GI Holdings Inc. stock A Buy?
There is no support from accumulated volume below today's level and given the right condition the stock may perform very badly in the next couple of days.
Insiders are positive buying more shares than they are selling in Motus GI Holdings Inc
Motus GI Holdings Inc. holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.
Golden Star Signal
In the last 100 trades there were 4.08 million shares bought and 1.61 million shares sold. The last trade was done 17 days ago by Nelson Sonja who bough 50 thousand shares. The large amount of stocks bought compared to stocks sold indicate that the insiders believe there is a potential good upside.
Top Fintech Company
This unique signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star. This signal is rare and, in most cases, gives substantial returns. From 10 000+ stocks usually only a few will trigger a Golden Star Signal per day!
What is Motus GI Holdings?
featured in The Global Fintech Index 2020 as the top Fintech company of the country.
What is Rocky88888888888?
Pivoting off Support and up-trending towards Resistance Motus GI Holdings, Inc., a medical technology company, provides endoscopy solutions that enhance clinical outcomes and the cost-efficiency associated with colonoscopy in the United States and Israel. Its flagship product is the Pure-Vu system, a medical device to facilitate the cleaning of a poorly prepared...
Motus GI (MOTS)
Pivoting off Support and up-trending towards Resistance Motus GI Holdings, Inc., a medical technology company, provides endoscopy solutions that enhance clinical outcomes and the cost-efficiency associated with colonoscopy in the United States and Israel.
Motus GI Holdings, Inc. - Hold
This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.
Style Scorecard
Zacks' proprietary data indicates that Motus GI Holdings, Inc. is currently rated as a Zacks Rank 3 and we are expecting an inline return from the MOTS shares relative to the market in the next few months. In addition, Motus GI Holdings, Inc.
MOTS earnings per share forecast
The Zacks Equity Research reports, or ZER for short, are our in-house, independently produced research reports.
MOTS revenue forecast
What is MOTS 's earnings per share in the next 2 years based on estimates from 5 analyst s?
MOTS revenue growth forecast
What is MOTS 's revenue in the next 2 years based on estimates from 3 analyst s?
